5 Ways the Gilead-Kite Acquisition Might be Profitable
While company acquisitions are sometimes cause for alarm among investors, Gilead Sciences’ (NASDAQ:$GILD) recent buyout of Kite Pharma (NASDAQ:$KITE) at $180 per share may have been a smart move toward long-term growth and profitable outcomes …
The Man Who Spiked Up The Price of Daraprim, Martin Shkreli, Found Guilty of Three Counts of Securities Fraud
On Friday, August 4th, the infamous “Pharma bro” Martin Shkreli was found guilty of three counts of securities fraud. However, he was found not guilty of five other crimes he had been accused of regarding …
Vertex Pharmaceuticals Shares Increased 24% Today
On July 18, Vertex Pharmaceuticals Inc. (NASDAQ:$VRTX) shares skyrocketed in an after hours trading session. This added about $8 billion to the Boston-based company’s value. What caused the increase? Shares of the company soared after …
5 Pharma and Biotech Stocks to Watch as We Approach the Healthcare Sector Earnings
It seems like pharmaceutical and biotech stocks are making a comeback. And there are several, justifiable reasons for this improved performance. For starters, investors seem to be more comfortable with the drug pricing scenario and …
Novartis’ Cutting-Edge Cancer Therapy Gains Critical Recommendation from FDA Advisory Committee
An advisory committee at the U.S. Food and Drug Administration (FDA) just gave a critical recommendation for pharmaceutical company Novartis’ (NYSE:$NVS) new cancer therapy. The data for the therapy, called CTL019 and developed to treat …
Sanofi to Buy Protein Sciences For $650 Million
It has been announced that Sanofi (OTC:$SNYNF), a French pharmaceutical company, will be purchasing Protein Sciences, a privately-held U.S. vaccines biotech company, for $650 million. This deal indicates that Sanofi is going forward with its …
An Analyst Upgraded TherapeuticsMD Stock from “Perform” to “Outperform” Today
On Tuesday, after Jay Olson, an analyst at Oppenheimer, upgraded TherapeuticsMD (NYSEMKT:$TXMD) stock from “Perform” to “Outperform”, shares of TXMD increased 18%. Additionally, the analyst gave TherapeuticsMD shares a $10 price target, which means that …
Lupin Limited Gets Final Go Ahead for its Oxycodone Hydrochloride Tablets
Lupin Limited (NSE: LUPIN), a major pharmaceutical company, has acquired the final approval from the United States FDA for its Oxycodone Hydrochloride tablets. These tablets will be used to treat patients suffering from severe pain. …
Dr Reddy’s Calls for a Recall of $5,030 USD of Zenatane Tablets from US market
Are you thinking about investing in pharmaceutical companies? If so, let’s take a look at what’s been happening in this sector of the market as of late.
Dr Reddy’s Laboratories (NYSE:$RDY), an Indian …